Creating a Robust Pricing Compliance/Audit Program That Will Provide the Most Accurate Calculations and the Ability to Verify Them
March 11, 2009
Foley Partner Lena Robins is speaking at the American Conference Institute’s (ACI) 7th Annual Advanced forum on Government Regulation of Prescription Drug Pricing, March 11 – 12, 2009 in New York, New York.
Ms. Robins is speaking on March 11, 2009 at 4:15 p.m. Her session is titled “Creating a Robust Pricing Compliance/Audit Program That Will Provide the Most Accurate Calculations and the Ability to Verify Them.” Topics to be covered include:
- Developing a compliance program that conforms to HHS OIG draft Compliance Program Guidance for the pharmaceutical industry
- Reducing risk in the three areas identified by the OIG as the most problematic:
- integrity of data
- kickbacks and illegal remuneration
- samples
- integrity of data
- Defining the relationship between the government pricing function and the compliance department
- what role does or should the finance department play?
- Weighing the pros and cons of outsourcing calculations
- what can or should be outsourced?
- ensuring that outsources calculations are correct
- what is the government’s position on outsourcing calculations?
Related Insights
June 16, 2025
Energy Current
U.S. Senate Proposes Changes to ITC and PTC
The Senate Finance Committee has released draft legislation proposing a phasedown of the ITC and PTC for solar and wind projects beginning in 2026. Learn what this could mean for renewable energy developers.
June 16, 2025
Labor & Employment Law Perspectives
Be Aware of Liability for Prevailing Wage Requirements, Which Can be Significant!
A new lawsuit in Pennsylvania highlights the risks for contractors on public works projects who misclassify workers or fail to pay prevailing wages. Learn about key compliance takeaways.
June 16, 2025
Labor & Employment Law Perspectives
Indiana Adds More Restrictions on Physician Noncompete Agreements
Indiana has enacted a new law banning physician noncompete agreements with hospitals and related entities, adding to prior restrictions passed in 2020 and 2023. Learn what this means for healthcare employers.